Literature DB >> 11923891

Organizational and activational effects of estrogenic endocrine disrupting chemicals.

Ellen K Silbergeld1, Jodi A Flaws, Ken M Brown.   

Abstract

Endocrine disruption is a hypothesis of common mode of action that may define a set of structurally varied chemicals, both natural and synthetic. Their common mode of action may suggest that they produce or contribute to similar toxic effects, although this has been difficult to demonstrate. Insights from developmental biology suggest that development of hormone sensitive systems, such as the brain and the genitourinary tract, may be particularly sensitive to EDCs. Because these systems are both organized and later activated by hormones, the brain and vagina may be valuable model systems to study the toxicity of EDCs in females and to elucidate mechanisms whereby early exposures appear to affect long term function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923891     DOI: 10.1590/s0102-311x2002000200014

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  5 in total

1.  Toxicity evaluation of bisphenol A administered by gavage to Sprague Dawley rats from gestation day 6 through postnatal day 90.

Authors:  K Barry Delclos; Luísa Camacho; Sherry M Lewis; Michelle M Vanlandingham; John R Latendresse; Greg R Olson; Kelly J Davis; Ralph E Patton; Gonçalo Gamboa da Costa; Kellie A Woodling; Matthew S Bryant; Mani Chidambaram; Raul Trbojevich; Beth E Juliar; Robert P Felton; Brett T Thorn
Journal:  Toxicol Sci       Date:  2014-02-04       Impact factor: 4.849

2.  Prenatal Programming and Toxicity (PPTOX) Introduction.

Authors:  Linda S Birnbaum; Mark F Miller
Journal:  Endocrinology       Date:  2015-08-04       Impact factor: 4.736

Review 3.  Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals.

Authors:  Anna Beronius; Laura N Vandenberg
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

4.  A path forward in the debate over health impacts of endocrine disrupting chemicals.

Authors:  R Thomas Zoeller; Åke Bergman; Georg Becher; Poul Bjerregaard; Riana Bornman; Ingvar Brandt; Taisen Iguchi; Susan Jobling; Karen A Kidd; Andreas Kortenkamp; Niels E Skakkebaek; Jorma Toppari; Laura N Vandenberg
Journal:  Environ Health       Date:  2014-12-22       Impact factor: 5.984

5.  Fetal programming: in utero exposure to acrylamide leads to intergenerational disrupted ovarian function and accelerated ovarian aging.

Authors:  Nouf Aldawood; Maroua Jalouli; Abdulkarem Alrezaki; Saber Nahdi; Abdullah Alamri; Mohamed Alanazi; Salim Manoharadas; Saleh Alwasel; Abdel Halim Harrath
Journal:  Aging (Albany NY)       Date:  2022-09-06       Impact factor: 5.955

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.